Procter & Gamble Hygiene and Health Care Limited is engaged in the manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses. Its portfolio includes WHISPER – India’s leading Feminine Hygiene brand, and VICKS – India’s No. 1 Health Care brand and Old Spice.
The company possesses a wide moat rooted in powerful brand equity and a dominant scale-based distribution network. This is corroborated by exceptionally high and stable average ROCE exceeding 90% and durable net margins near 17%, indicating significant competitive advantages and pricing power.
Management prioritizes high-return internal reinvestment followed by substantial dividend payouts, including special dividends to return excess cash. The company maintains a debt-free balance sheet and high cash conversion, reflecting disciplined capital management.
The investment collapsed as the parent company prioritized its global interests over minority shareholders, siphoning off profits through escalating royalty fees and related-party contract manufacturing. Stagnant revenue growth, which was already modest at 6.5%, failed to keep pace with inflation as local competitors eroded the brand's premium positioning. The revolving door of leadership led to strategic drift, and the intercorporate loan to a group entity proved to be the first of many capital misallocations that drained the once-pristine balance sheet.
RichFakir rates Procter & Gamble Hygiene and Health Care Ltd's business quality as wonderful — 73/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as wide.
On our model, Procter & Gamble Hygiene and Health Care Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Procter & Gamble Hygiene and Health Care Ltd is: Watch — wait for price. A wonderful business, but at an expensive price against our estimate of fair value — one to keep on the watchlist for a better entry.
RichFakir's educational estimate of Procter & Gamble Hygiene and Health Care Ltd's fair value is about ₹2,716 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →